Atlas Trials

ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures

Clinical trial NCT00404924 · COMPLETED

Trial details

NCT number
NCT00404924
Sponsor
Genzyme, a Sanofi Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Non-Small-Cell Lung Carcinoma
Start date
2006-11-01
Primary completion
2009-10-01
Enrollment
1140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.